185 related articles for article (PubMed ID: 19589228)
1. Preparation and in-vitro bioactivity of a novel superantigen conjugate targeting bladder carcinoma.
Zhen G; Cong-hui H; Lin H; Jian-jun Y; Wen-hao T; Gao-jun T
J Pharm Pharmacol; 2009 Jul; 61(7):869-75. PubMed ID: 19589228
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of monoclonal antibody-coupled Staphylococcus superantigen-A induced apoptosis in human bladder cancer cells.
Han C; Gong Z; Hao L; Yang J; Hu J; Dong B; Fan T; Tang W; Teng G
Cell Biochem Biophys; 2011 Dec; 61(3):679-84. PubMed ID: 21769564
[TBL] [Abstract][Full Text] [Related]
3. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
Litton MJ; Dohlsten M; Lando PA; Kalland T; Ohlsson L; Andersson J; Andersson U
Eur J Immunol; 1996 Jan; 26(1):1-9. PubMed ID: 8566049
[TBL] [Abstract][Full Text] [Related]
4. Preparation and activity of conjugate of monoclonal antibody HAb18 against hepatoma F(ab')(2) fragment and staphylococcal enterotoxin A.
Yang LJ; Sui YF; Chen ZN
World J Gastroenterol; 2001 Apr; 7(2):216-21. PubMed ID: 11819763
[TBL] [Abstract][Full Text] [Related]
5. Superantigen-activated mononuclear cells induce apoptosis in transitional cell carcinoma.
Perabo FG; Willert PL; Wirger A; Schmidt DH; Von Ruecker A; Mueller SC
Anticancer Res; 2005; 25(5):3565-73. PubMed ID: 16101181
[TBL] [Abstract][Full Text] [Related]
6. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
[TBL] [Abstract][Full Text] [Related]
7. Perforin and IFN-gamma are involved in the antitumor effects of antibody-targeted superantigens.
Rosendahl A; Kristensson K; Hansson J; Riesbeck K; Kalland T; Dohlsten M
J Immunol; 1998 Jun; 160(11):5309-13. PubMed ID: 9605129
[TBL] [Abstract][Full Text] [Related]
8. A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC.
Wang S; Li Y; Xiong H; Cao J
Immunol Lett; 2008 Dec; 121(2):167-72. PubMed ID: 19028523
[TBL] [Abstract][Full Text] [Related]
9. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
Kum WW; Chow AW
J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitive effect and mechanism of monoclonal antibody targeted SEA on human bladder cancer cell line BIU-87].
Gong Z; Zhang PY; Han CH; Hao L; Yang JJ; Wang T; Tang WH
Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1234-8. PubMed ID: 20646593
[TBL] [Abstract][Full Text] [Related]
12. MHC class I-related chain A conjugated to antitumor antibodies can sensitize tumor cells to specific lysis by natural killer cells.
Germain C; Larbouret C; Cesson V; Donda A; Held W; Mach JP; Pèlegrin A; Robert B
Clin Cancer Res; 2005 Oct; 11(20):7516-22. PubMed ID: 16243826
[TBL] [Abstract][Full Text] [Related]
13. Anti-HLA class I antibody inhibits Staphylococcus enterotoxin A (SEA)-induced proliferation of human PBMC.
Baskar P; Hildreth JE; Chrest FJ; Nagel JE; Adler WH
Cell Immunol; 1996 Aug; 172(1):135-8. PubMed ID: 8806816
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393
[TBL] [Abstract][Full Text] [Related]
15. Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.
Sundstedt A; Celander M; Hedlund G
Int Immunopharmacol; 2008 Mar; 8(3):442-52. PubMed ID: 18279798
[TBL] [Abstract][Full Text] [Related]
16. A neutralizing epitope of the superantigen SEA has agonist activity on T cells.
Hobeika AC; Johnson HM
Biochem Biophys Res Commun; 1996 Jun; 223(3):565-71. PubMed ID: 8687436
[TBL] [Abstract][Full Text] [Related]
17. Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells.
Holzer U; Bethge W; Krull F; Ihle J; Handgretinger R; Reisfeld RA; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
Cancer Immunol Immunother; 1995 Aug; 41(2):129-36. PubMed ID: 7656271
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of the interaction between the superantigen staphylococcal enterotoxin A and the TCR.
Antonsson P; Wingren AG; Hansson J; Kalland T; Varga M; Dohlsten M
J Immunol; 1997 May; 158(9):4245-51. PubMed ID: 9126986
[TBL] [Abstract][Full Text] [Related]
19. Antibody to human MHC class I inhibits SIVsmmPBj1.9-induced proliferation of pigtailed macaque lymphocytes.
Baskar PV; Nagel JE; Narayan O; McClure HM; Adler WH; Hildreth JE
Exp Clin Immunogenet; 1997; 14(2):141-8. PubMed ID: 9395890
[TBL] [Abstract][Full Text] [Related]
20. Effective adoptive immunotherapy by T-LAK cells retargeted with bacterial superantigen-conjugated antibody to MUC1 in xenografted severe combined immunodeficient mice.
Shinoda M; Kudo T; Suzuki M; Katayose Y; Sakurai N; Saeki H; Kodama H; Fukuhara K; Imai K; Hinoda Y; Matsuno S
Cancer Res; 1998 Jul; 58(13):2838-43. PubMed ID: 9661899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
